Protective effect of crocin on acrolein-induced tau phosphorylation in the rat brain

Acta Neurobiologiae Experimentalis

Volumn 75, Issue 2, 2015, Pages 208-219

  Rashedinia, Marzieh ^a   Lari, Parisa ^b   Abnous, Khalil ^c   Hosseinzadeh, Hossein ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acrolein; Alzheimer s disease; Amyloid ; Crocin; Mitogen activated protein kinases; Tau phosphorylation

Indexed keywords

ACROLEIN; CAROTENOID; CROCIN; GLUTATHIONE; MAPT PROTEIN, RAT; NEUROPROTECTIVE AGENT; TAU PROTEIN;

ANIMAL; BRAIN; DRUG EFFECTS; LIPID PEROXIDATION; MALE; METABOLISM; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PHOSPHORYLATION; WISTAR RAT;

ACROLEIN; ANIMALS; BRAIN; CAROTENOIDS; GLUTATHIONE; LIPID PEROXIDATION; MALE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHOSPHORYLATION; RATS, WISTAR; TAU PROTEINS;

EID: 84937709527     PISSN: 00651400     EISSN: 16890035     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Alavizadeh SH, Hosseinzadeh H (2014) Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol 64: 65-80.
2. Amin B, Hosseinzadeh H (2012) Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia 83: 888-895.
3. Assimopoulou A, Sinakos Z, Papageorgiou V (2005) Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res 19: 997-1000.
4. Boskabady M H, Tabatabaee A, Byrami G (2012) The effect of the extract of Crocus sativus and its constituent safranal, on lung pathology and lung inflammation of ovalbumin sensitized guinea-pigs. Phytomedicine 19: 904-911.
5. Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72: 751-756.
6. Carroll JC, Iba M, Bangasser DA, Valentino RJ, James MJ, Brunden KR, Lee VM-Y, Trojanowski JQ (2011) Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J Neurosci 31: 14436-14449.
7. Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribe E, Dalfo E, Avila J (2005) Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimers disease and tauopathies. Curr. Alzheimer Res 2: 3-18.
8. Ghadrdoost B, Vafaei A A, Rashidy-Pour A, Hajisoltani R, Bandegi A R, Motamedi F, Haghighi S, Sameni HR, Pahlvan S (2011) Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur J Pharm 667: 222-229.
9. Ghahghaei A, Bathaie SZ, Bahraminejad E (2012) Mechanisms of the effects of crocin on aggregation and deposition of Aβ1-40 fibrils in Alzheimer's disease. Int J Peptide Res Ther 18: 347-351.
10. Gómez-Ramos A, Díaz-Nido J, Smith MA, Perry G, Avila J (2002) Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. J Neurosci Res 71: 863-870.
11. Gómez-Ramos A, Smith MA, Perry G, Avila J (2004) Tau phosphorylation and assembly. Acta Neurobiol Exp (Wars) 64: 33-40.
12. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, O'Connor R, O'Neill C (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 93: 105-117.
13. Hadizadeh F, Mohajeri S, Seifi M (2010) Extraction and purification of crocin from saffron stigmas employing a simple and efficient crystallization method. Pakistan J Biol Sci 13: 691.
14. Hariri AT, Moallem SA, Mahmoudi M, Hosseinzadeh H (2011) The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine 18: 499-504.
15. Hosseinzadeh H, Nassiri-Asl M (2012) Avicenna's (Ibn Sina) the Canon of Medicine and Saffron (Crocus sativus): A Review. Phytother Rese 27: 475-483.
16. Hosseinzadeh H, Sadeghnia HR (2005) Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 8: 394-399.
17. Hosseinzadeh H, Younesi HM (2002) Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2: 7.
18. Hosseinzadeh H, Ziaei T (2006) Effects of Crocus sativus stigma extract and its constituents, crocin and safranal, on intact memory and scopolamine-induced learning deficits in rats performing the Morris water maze task. J Med Plants 5: 40-50.
19. Hosseinzadeh H, Karimi G, Niapoor M (2003) Antidepressant effect of Crocus sativus L. stigma extracts and their constituents, crocin and safranal, in mice. International Symposium on Saffron Biology and Biotechnology 650: 435-445.
20. Hosseinzadeh H, Motamedshariaty V, Hadizadeh F (2007) Antidepressant effect of kaempferol, a constituent of saffron (Crocus sativus) petal, in mice and rats. Pharmacology online 2: 367-370.
21. Hosseinzadeh H, Sadeghnia HR, Rahimi A (2008) Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic acid treatment in anesthetized rats. Planta Med 74: 1441-1445.
22. Hosseinzadeh H, Shamsaie F, Mehri S (2009) Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents, crocin and safranal. Pharmacogn Mag 5: 419.
23. Hosseinzadeh H, Modaghegh MH, Saffari Z (2009) Crocus sativus L. (Saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. Evid Based Complement Alternat Med 6: 343-350.
24. Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, Motamedshariaty VS, Mohajeri SA (2012) Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Rese 26: 381-386.
25. Huang HC, Jiang ZF (2009) Accumulated amyloid-β peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. J Alzheimers Dis 16: 15-27.
26. Huang YJ, Jin MH, Pi RB, Zhang JJ, Ouyang Y, Chao XJ, Chen MH, Liu PQ, Yu JC, Ramassamy C (2013a) Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo. Toxicol Lett 217: 184-191.
27. Huang Y, Jin M, Pi R, Zhang J, Chen M, Ouyang Y, Liu A, Chao X, Liu P, Liu J (2013b) Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells. Neurosci Lett 535: 146-151.
28. Kehrer JP, Biswal SS (2000) The molecular effects of acrolein. Toxicol Sci 57: 6-15.
29. Lari P, Abnous K, Imenshahidi M, Rashedinia M, Razavi M, Hosseinzadeh H (2013) Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin. Toxicol Ind Health 31: 367-376.
30. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-1159.
31. LoPachin RM, Gavin T, Petersen DR, Barber DS (2009) Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol 22: 1499-1508.
32. Lovell MA, Xie C, Markesbery WR (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22: 187-194.
33. Mehri S, Abnous K, Mousavi SH, Shariaty VM, Hosseinzadeh H (2012) Neuroprotective effect of crocin on acrylamideinduced cytotoxicity in PC12 cells. Cell Mol Neurobiol 32: 227-235.
34. Migliore L, Coppedè F (2009) Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat. Res-Gen Tox En 674: 73-84.
35. Mohammadpour AH, Ayati Z, Parizadeh MR, Rajbai O, Hosseinzadeh H (2013) Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci 16: 39-46.
36. Mondragón-Rodríguez S, Perry G, Zhu X, Boehm J (2012) Amyloid beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy. Int J Alzheimers Dis 2012: 630182.
37. Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione-Stransferase activities in rat lung and liver. BBA-Gen Subjects 582: 67-78.
38. Muñoz-Montaño JR, Moreno FJ, Avila J, Díaz-Nido J (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS letters 411: 183-188.
39. Ochiai T, Shimeno H, Mishima K, Iwasaki K, Fujiwara M, Tanaka H, Shoyama Y, Toda A, Eyanagi R, Soeda S (2007) Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta 1770: 578-584.
40. Ramassamy C, Arseneault M, Nam DT (2010) Free radical-mediated damage to brain in Alzheimer's disease: role of acrolein and preclinical promise of antioxidant polyphenols. In: Aging and Age-Related Disorders (Bondy S, Maiese K, Eds). Humana Press, p. 417-437.
41. Rankin CA, Sun Q, Gamblin TC (2007) Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol Neurodegener 2: 12.
42. Rashedinia M, Lari P, Abnous KH, Hosseinzadeh H (2013) Proteomic analysis of rat cerebral cortex following subchronic acrolein toxicity. Toxicol Appl Pharm 272: 199-207.
43. Rastgoo M, Hosseinzadeh H, Alavizadeh H, Abbasi A, Ayati Z, Jaafari M R (2013) Anti-tumor activity of PEGylated nanoliposome containing crocin in mice bearing C26 colon carcinoma. Planta Med 79: 447-451.
44. Razavi BM, Hosseinzadeh H, Movassaghi AR, Imenshahidi M, Abnous K (2013a) Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. Chem Biol Interact 203: 547-555.
45. Razavi M, Hosseinzadeh H, Abnous K, Motamedshariaty VS, Imenshahidi M (2013b) Crocin restores hypotensive effect of subchronic diazinon administration in rat. Iran J Basic Med Sci 16: 64-72.
46. Rezaee R, Hosseinzadeh H (2013) Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci 16: 12.
47. Sahebari M, Mahmoudi Z, Rabe SZT, Haghmorad D, Mahmoudi MB, Hosseinzadeh H, Tabasi N, Mahmoudi M (2011) Inhibitory effect of aqueous extract of saffron (crocus sativus l.) on adjuvant induced arthritis in wistar rat. pharmacologyonline 3: 802-808.
48. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96: 1005-1015.
49. Stevens JF, Maier CS (2008) Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 52: 7-25.
50. Su B, Wang X, Nunomura A, Moreira PI, Lee H-G, Perry G, Smith MA, Zhu X (2008) Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res 5: 525.
51. Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19:341-53.
52. Thomas A, Ballard C, Kenny RA, O'Brien J, Oakley A, Kalaria R (2005) Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia. Demen Geriatr Cogn 19:57-60.
53. Vahdati FH, Naseri V, Razavi B M, Mehri S, Abnous K, Hosseinzadeh H (2014) Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. Daru 22: 16.
54. Wang Y, Han T, Zhu Y, Zheng C J, Ming Q L, Rahman K, Qin L P (2010). Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 64: 24-30.
55. Yavuz Ö, Türközkan N, Dogulu F, Aykol S (1997) The effect of 2-chloroadenosine on lipid peroxide level during experimental cerebral ischemia-reperfusion in gerbils. Free Radic Biol Med 22: 337-341.
56. Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S (2011) Retracted: Implication of phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation. J Ethnopharmacol 133: 1109-1116.
57. Zhu X, Lee HG, Raina AK, Perry G, Smith MA (2002) The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11: 270-281.